0001209191-18-002554.txt : 20180105 0001209191-18-002554.hdr.sgml : 20180105 20180105185539 ACCESSION NUMBER: 0001209191-18-002554 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180105 FILED AS OF DATE: 20180105 DATE AS OF CHANGE: 20180105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chevallard Daniel R. CENTRAL INDEX KEY: 0001706176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 18514520 MAIL ADDRESS: STREET 1: C/O REGULUS THERAPEUTICS INC. STREET 2: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-05 0 0001505512 Regulus Therapeutics Inc. RGLS 0001706176 Chevallard Daniel R. C/O REGULUS THERAPEUTICS INC. 10614 SCIENCE CENTER DR. SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 1.24 2018-01-05 4 A 0 350000 0.00 A 2028-01-04 Common Stock 350000 350000 D The option will vest in forty-eight equal monthly installments, such that the option will be fully vested four years from the date of grant, subject to the Reporting Person's continuous service to us. Christopher Aker, Attorney in Fact 2018-01-05